Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer
Enteral or parenteral nutrition: Patients who did not receive enteral or parenteral nutrition during neoadjuvant treatment.
Study summary
Malnutrition is common at the time of diagnosis of esogastric cancers. However, there are no recommendations regarding preoperative nutritional support (type and duration) or on the impact of refeeding on postoperative morbidity and mortality.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patient undergoing surgery for esophageal cancer
* Malnourished patient at the time of management
* Receiving neoadjuvant treatment
Exclusion Criteria:
* Patient not malnourished at the time of management
* Patient who did not receive neoadjuvant treatment
Primary outcome measure(s)
Rate of postoperative complications according to the Clavien classification — Day 30 Proportion of patients experiencing at least one postoperative complication, classified according to Clavien-Dindo, in malnourished patients with versus without nutritional support.
Trial sites (1)
Facility
City
Region
Status
Hopîtal du Haut Lévêque
Pessac
France
Recruiting
More University Hospital, Bordeaux trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
